Private Advisor Group’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-9,481
| Closed | -$367K | – | 2152 |
|
|
2022
Q1 | $367K | Buy |
9,481
+1,938
| +26% | +$75K | ﹤0.01% | 1565 |
|
|
2021
Q4 | $442K | Sell |
7,543
-4,757
| -39% | -$279K | ﹤0.01% | 1502 |
|
|
2021
Q3 | $730K | Buy |
12,300
+6,044
| +97% | +$359K | ﹤0.01% | 1342 |
|
|
2021
Q2 | $543K | Buy |
6,256
+38
| +0.6% | +$3.3K | ﹤0.01% | 1349 |
|
|
2021
Q1 | $512K | Buy |
6,218
+95
| +2% | +$7.82K | ﹤0.01% | 1289 |
|
|
2020
Q4 | $557K | Buy |
6,123
+1,123
| +22% | +$102K | 0.01% | 1168 |
|
|
2020
Q3 | $200K | Hold |
5,000
| – | – | ﹤0.01% | 1405 |
|
|
2020
Q2 | $172K | Buy |
+5,000
| New | +$172K | ﹤0.01% | 1433 |
|